Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 1991;83(1-2):37-42.
doi: 10.1007/BF01244450.

Prolactin responses to haloperidol in drug-free and treated schizophrenic patients

Affiliations
Comparative Study

Prolactin responses to haloperidol in drug-free and treated schizophrenic patients

M Markianos et al. J Neural Transm Gen Sect. 1991.

Abstract

The prolactin response to 5 mg haloperidol i.m. was studied in 12 schizophrenic patients in a drug-free state and after a month treatment with haloperidol, as a possible index of dopamine receptor sensitivity and occupancy. Blood samples were taken at times 0, 60, 90 and 120 minutes. The increase in PRL observed in the drug-free state disappeared after drug treatment. The PRL plasma levels after treatment with 60 mg haloperidol per os were higher than the maximal PRL responses after 5 mg i.m. The increases in baseline PRL caused by the treatment correlated positively to the reduction in the BPRS score. The test was also performed in a group of 11 patients chronically treated with haloperidol during a daily dose of 60 mg, and 15 days after reduction of the dose to 30 mg. PRL increases after 5 mg haloperidol i.m. were observed only after reduction of the dose. It is suggested that the prolactin response to haloperidol is an index of the occupancy of receptors that are involved in the PRL releasing mechanisms, and could be used to verify their blockade by the neuroleptics, especially in patients that do not respond positively to drug treatment.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Am J Psychiatry. 1987 Oct;144(10):1335-7 - PubMed
    1. Psychopharmacology (Berl). 1979 Mar 14;61(1):17-24 - PubMed
    1. Arch Gen Psychiatry. 1978 Jan;35(1):108-16 - PubMed
    1. Psychiatry Res. 1983 Aug;9(4):285-99 - PubMed
    1. Psychopharmacology (Berl). 1980 Jan;67(1):17-23 - PubMed

Publication types

LinkOut - more resources